Moreover, a study using FGFR4 rs351855-A/A-knockin transgenic mice to investigate lung cancer observed a marked decrease in the number of tumor-infiltrating CD8-positive T cells and a significant increase in regulatory T cell proportions compared with those from the G/G-knockin mice [46]. The gene discussed is FGFR4; the disease is lung carcinoma.